DiscoverAt the Intersection of Science and LawIncentivizing diverse representation in clinical trials
Incentivizing diverse representation in clinical trials

Incentivizing diverse representation in clinical trials

Update: 2022-03-02
Share

Description

Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.

See omnystudio.com/listener for privacy information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Incentivizing diverse representation in clinical trials

Incentivizing diverse representation in clinical trials

DLA Piper